|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2 Pt 1
|
|
pubmed:dateCreated |
1993-3-17
|
|
pubmed:abstractText |
Atopic dermatitis is characterized by immunologic abnormalities including evidence for reduced interferon gamma production. Therapeutic options for treatment of atopic dermatitis are limited and unsatisfactory. Previous open trials have suggested efficacy for recombinant interferon-gamma (rIFN-gamma) in treatment of severe atopic dermatitis. We describe the results of treatment with rIFN-gamma, assessing clinical, immunologic, and laboratory safety parameters in 83 patients with moderate to severe atopic dermatitis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0190-9622
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
N
|
|
pubmed:pagination |
189-97
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:8432915-Adolescent,
pubmed-meshheading:8432915-Adult,
pubmed-meshheading:8432915-Age Factors,
pubmed-meshheading:8432915-Aged,
pubmed-meshheading:8432915-Child,
pubmed-meshheading:8432915-Child, Preschool,
pubmed-meshheading:8432915-Dermatitis, Atopic,
pubmed-meshheading:8432915-Dose-Response Relationship, Drug,
pubmed-meshheading:8432915-Double-Blind Method,
pubmed-meshheading:8432915-Female,
pubmed-meshheading:8432915-Follow-Up Studies,
pubmed-meshheading:8432915-Humans,
pubmed-meshheading:8432915-Immunoglobulin E,
pubmed-meshheading:8432915-Injections, Subcutaneous,
pubmed-meshheading:8432915-Interferon-gamma,
pubmed-meshheading:8432915-Male,
pubmed-meshheading:8432915-Middle Aged,
pubmed-meshheading:8432915-Recombinant Proteins,
pubmed-meshheading:8432915-Severity of Illness Index
|
|
pubmed:year |
1993
|
|
pubmed:articleTitle |
Recombinant interferon gamma therapy for atopic dermatitis.
|
|
pubmed:affiliation |
Department of Dermatology, Oregon Health Sciences University, Portland 97201-3098.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
